For serum AFP, AFP-L3% and PIVKA-II detection, the results of this study suggested that the diagnostic models GALAD, ASAP, GALAD-C and C-GALAD are recommended preferentially in the diagnosis of liver cancers (including HCC, CCA and their early stages). Here, AFP is linked to hepatocellular carcinoma.